Header Logo

Connection

Heather Feigelson to Male

Back to Details
This is a "connection" page, showing publications Heather Feigelson has written about Male.
Heather Feigelson
Connection Strength
0.984
Male
  1. The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship. BMC Cancer. 2022 Feb 25; 22(1):209.
    View in: PubMed
    Score: 0.078
  2. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer. 2020 May 03; 20(1):373.
    View in: PubMed
    Score: 0.068
  3. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study. Cancer Med. 2019 08; 8(9):4508-4516.
    View in: PubMed
    Score: 0.064
  4. Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network. Cancer Causes Control. 2019 Jul; 30(7):747-755.
    View in: PubMed
    Score: 0.064
  5. Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey. Support Care Cancer. 2019 Jan; 27(1):147-156.
    View in: PubMed
    Score: 0.060
  6. Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors. J Cancer Surviv. 2017 Jun; 11(3):393-400.
    View in: PubMed
    Score: 0.054
  7. Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. PLoS One. 2014; 9(5):e94977.
    View in: PubMed
    Score: 0.045
  8. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet. 2010 Oct 01; 19(19):3873-84.
    View in: PubMed
    Score: 0.035
  9. Successful genome-wide scan in paired blood and buccal samples. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):1023-5.
    View in: PubMed
    Score: 0.028
  10. Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP. Eur J Hum Genet. 2015 Feb; 23(2):260-3.
    View in: PubMed
    Score: 0.023
  11. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med. 2013 Dec; 15(12):933-40.
    View in: PubMed
    Score: 0.021
  12. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. Lancet Oncol. 2022 11; 23(11):1451-1464.
    View in: PubMed
    Score: 0.020
  13. Determinants of DNA yield and quality from buccal cell samples collected with mouthwash. Cancer Epidemiol Biomarkers Prev. 2001 Sep; 10(9):1005-8.
    View in: PubMed
    Score: 0.019
  14. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res. 2001 Jan 15; 61(2):785-9.
    View in: PubMed
    Score: 0.018
  15. Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Drug Metab Rev. 1998 May; 30(2):421-34.
    View in: PubMed
    Score: 0.015
  16. Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
    View in: PubMed
    Score: 0.014
  17. Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis. Cancer Causes Control. 2018 01; 29(1):143-156.
    View in: PubMed
    Score: 0.014
  18. Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery. Obesity (Silver Spring). 2017 11; 25 Suppl 2:S52-S57.
    View in: PubMed
    Score: 0.014
  19. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
    View in: PubMed
    Score: 0.014
  20. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat. 2016 Feb; 155(3):531-40.
    View in: PubMed
    Score: 0.013
  21. Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem Suppl. 1996; 25:15-22.
    View in: PubMed
    Score: 0.013
  22. Socioeconomic Factors Affect Outcomes in Well-Differentiated Thyroid Cancer. Otolaryngol Head Neck Surg. 2016 Mar; 154(3):440-5.
    View in: PubMed
    Score: 0.013
  23. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol. 1994 Sep 15; 140(6):526-34.
    View in: PubMed
    Score: 0.012
  24. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.011
  25. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr. 2013 Aug 01; 167(8):700-7.
    View in: PubMed
    Score: 0.011
  26. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
    View in: PubMed
    Score: 0.010
  27. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012 Jun 13; 307(22):2400-9.
    View in: PubMed
    Score: 0.010
  28. Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J Genet Couns. 2012 Jun; 21(3):448-61.
    View in: PubMed
    Score: 0.010
  29. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011 Oct 01; 20(19):3867-75.
    View in: PubMed
    Score: 0.009
  30. Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet. 2011 Aug 15; 20(16):3322-9.
    View in: PubMed
    Score: 0.009
  31. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet. 2011 Jul 15; 20(14):2869-78.
    View in: PubMed
    Score: 0.009
  32. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet. 2011 Jun; 129(6):675-85.
    View in: PubMed
    Score: 0.009
  33. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs. 1991; 42 Suppl 5:16-21.
    View in: PubMed
    Score: 0.009
  34. Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol. 2010 Aug 15; 172(4):419-29.
    View in: PubMed
    Score: 0.009
  35. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab. 2010 Sep; 95(9):E121-7.
    View in: PubMed
    Score: 0.009
  36. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
    View in: PubMed
    Score: 0.009
  37. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res. 2010 Mar 15; 70(6):2389-96.
    View in: PubMed
    Score: 0.008
  38. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis. 2010 Mar; 31(3):455-61.
    View in: PubMed
    Score: 0.008
  39. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2734-44.
    View in: PubMed
    Score: 0.008
  40. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet. 2009 Oct; 41(10):1055-7.
    View in: PubMed
    Score: 0.008
  41. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet. 2009 Oct 01; 18(19):3749-57.
    View in: PubMed
    Score: 0.008
  42. Family history of various cancers and pancreatic cancer mortality in a large cohort. Cancer Causes Control. 2009 Oct; 20(8):1261-9.
    View in: PubMed
    Score: 0.008
  43. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7933-8.
    View in: PubMed
    Score: 0.008
  44. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet. 2008 Sep; 40(9):1032-4; author reply 1035-6.
    View in: PubMed
    Score: 0.008
  45. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One. 2008 Jul 02; 3(7):e2578.
    View in: PubMed
    Score: 0.008
  46. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008 Mar; 40(3):310-5.
    View in: PubMed
    Score: 0.007
  47. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):1973-81.
    View in: PubMed
    Score: 0.007
  48. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007 May; 39(5):645-9.
    View in: PubMed
    Score: 0.007
  49. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007 Apr 01; 67(7):2951-6.
    View in: PubMed
    Score: 0.007
  50. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005 12; 5(12):977-85.
    View in: PubMed
    Score: 0.006
  51. Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet. 2005 Nov; 1(5):e68.
    View in: PubMed
    Score: 0.006
  52. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002 May 01; 94(9):2490-501.
    View in: PubMed
    Score: 0.005
  53. Jewish ethnicity and prostate cancer mortality in two large US cohorts. Cancer Causes Control. 2002 Apr; 13(3):271-7.
    View in: PubMed
    Score: 0.005
  54. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002 Jan 15; 94(2):500-11.
    View in: PubMed
    Score: 0.005
  55. Declining cancer rates in the 1990s. J Clin Oncol. 2000 Jun; 18(11):2258-68.
    View in: PubMed
    Score: 0.004
  56. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res. 1998 Oct 15; 58(20):4497-504.
    View in: PubMed
    Score: 0.004
  57. IgE predicts future nonfatal myocardial infarction in men. J Clin Epidemiol. 1996 Feb; 49(2):203-9.
    View in: PubMed
    Score: 0.003
  58. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 Feb 06; 326(6):381-6.
    View in: PubMed
    Score: 0.002

© 2024 Kaiser Permanente